Ayse Bassez

4.3k total citations · 2 hit papers
8 papers, 1.5k citations indexed

About

Ayse Bassez is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Ayse Bassez has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Ayse Bassez's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers) and Immunotherapy and Immune Responses (2 papers). Ayse Bassez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers) and Immunotherapy and Immune Responses (2 papers). Ayse Bassez collaborates with scholars based in Belgium, United States and China. Ayse Bassez's co-authors include Diether Lambrechts, Bram Boeckx, Sara Aibar, Oliver T. Burton, Bernard Thienpont, Stein Aerts, Adrian Liston, David Nittner, Andreas Pircher and Els Wauters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Ayse Bassez

7 papers receiving 1.5k citations

Hit Papers

Phenotype molding of stromal cells in the lung tumor micr... 2018 2026 2020 2023 2018 2021 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayse Bassez Belgium 4 842 815 659 462 255 8 1.5k
David Nittner Belgium 13 753 0.9× 1.1k 1.3× 490 0.7× 657 1.4× 264 1.0× 18 1.7k
Zemin Zhang China 12 612 0.7× 559 0.7× 627 1.0× 298 0.6× 203 0.8× 23 1.3k
John Lövrot Sweden 13 923 1.1× 714 0.9× 466 0.7× 566 1.2× 220 0.9× 21 1.6k
Ilaria Magagna France 6 1.3k 1.5× 782 1.0× 731 1.1× 512 1.1× 154 0.6× 6 1.9k
Phuong Dao United States 3 643 0.8× 656 0.8× 739 1.1× 293 0.6× 120 0.5× 7 1.3k
Maxime Meylan France 9 850 1.0× 389 0.5× 700 1.1× 231 0.5× 308 1.2× 24 1.4k
Ruby Wasti France 2 621 0.7× 656 0.8× 707 1.1× 292 0.6× 121 0.5× 2 1.3k
Maria Toki United States 15 1.0k 1.2× 546 0.7× 732 1.1× 240 0.5× 391 1.5× 33 1.7k
Marcel P. Trefny Switzerland 9 1.0k 1.2× 445 0.5× 1.0k 1.5× 369 0.8× 220 0.9× 12 1.7k
Pedro Corrêa de Sampaio United States 11 837 1.0× 558 0.7× 418 0.6× 434 0.9× 80 0.3× 12 1.3k

Countries citing papers authored by Ayse Bassez

Since Specialization
Citations

This map shows the geographic impact of Ayse Bassez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayse Bassez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayse Bassez more than expected).

Fields of papers citing papers by Ayse Bassez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayse Bassez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayse Bassez. The network helps show where Ayse Bassez may publish in the future.

Co-authorship network of co-authors of Ayse Bassez

This figure shows the co-authorship network connecting the top 25 collaborators of Ayse Bassez. A scholar is included among the top collaborators of Ayse Bassez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayse Bassez. Ayse Bassez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Huijbers, Elisabeth J. M., Judy R. van Beijnum, Karlijn van Loon, et al.. (2025). Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy. Proceedings of the National Academy of Sciences. 122(12). e2424730122–e2424730122. 2 indexed citations
3.
Cappuyns, Sarah, Vincent Vandecaveye, Bram Boeckx, et al.. (2023). PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. Nature Communications. 14(1). 7825–7825. 33 indexed citations
4.
Richard, François, Maxim De Schepper, Tatjana Geukens, et al.. (2023). 14P Comparison of single-cell ERBB2 mRNA expression levels with HER2 status by immunohistochemistry reveals heterogeneity of the HER2-low status. ESMO Open. 8(1). 101238–101238.
5.
Vos, Hanne, Kathleen Lambein, François Richard, et al.. (2022). Abstract P2-08-23: Early intratumoral changes after a single dose of anti-PD-1 treatment in patients with early breast cancer (BC). Cancer Research. 82(4_Supplement). P2–8. 2 indexed citations
6.
Bassez, Ayse, Hanne Vos, Laurien Van Dyck, et al.. (2021). A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nature Medicine. 27(5). 820–832. 442 indexed citations breakdown →
7.
Vos, Hanne, Ayse Bassez, Junbin Qian, et al.. (2019). Immune cell dynamics induced by a single dose of pembrolizumab as revealed by single-cell RNA profiling. Annals of Oncology. 30. iii45–iii45. 1 indexed citations
8.
Lambrechts, Diether, Els Wauters, Bram Boeckx, et al.. (2018). Phenotype molding of stromal cells in the lung tumor microenvironment. Nature Medicine. 24(8). 1277–1289. 1037 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026